Homocysteine & Heart Disease: 7 Mechanisms Linking Elevated Levels to Cardiac Risk
Homocysteine as a Cardiovascular Risk Factor
Elevated plasma homocysteine (>15 µmol/L) independently predicts coronary, cerebral, and peripheral vascular events.
Pathogenic Mechanisms
- Endothelial injury: Reduces NO bioavailability, increases ADMA, promotes apoptosis.
- Pro-thrombotic state: ↑Tissue factor, ↓thrombomodulin, ↓protein C activation, ↑platelet adhesion, ↑Factor V/VII.
- Oxidative stress: Auto-oxidation generates H₂O₂, superoxide → LDL oxidation, foam cell formation.
- VSMC proliferation: Stimulates smooth muscle growth → intimal thickening, plaque progression.
- Collagen cross-linking defect: Impairs lysyl oxidase → weak fibrous cap → plaque rupture risk.
- Methylation disruption: SAM depletion → hypomethylation of DNA, altered gene expression.
- Inflammation: ↑MCP-1, IL-6, CRP → monocyte recruitment, plaque instability.
Clinical Implications
- Associated with MI, stroke, DVT/PE, heart failure, PAD.
- Folic acid (0.8–1 mg), B12 (500 µg), B6 (10–25 mg) lower levels but RCT outcomes mixed (HOPE-2, NORVIT).
- Screening: Consider in premature CVD, family history, renal disease.
Homocysteine is a marker of disrupted one-carbon metabolism; treatment targets underlying nutritional/renal/genetic causes.
Cardiovascular Disease - Related Articles
- Medical School Requirements for Cardiology: Grades, Coursework & Training Path
- Understanding and Addressing Arterial Plaque: A Comprehensive Guide
- L-Lysine and Heart Health: Benefits and Importance
- Understanding Invasive Cardiac Testing: Risks & Benefits
- Factors Affecting Pulse Oximetry Accuracy: A Clinical Guide
- Sympathetic Nervous System & Cardiovascular Response: Understanding Heart's Reaction
- Blood Pressure 151/91 mmHg at Age 60: Stage 2 Hypertension — Action Needed
